PD
MRVI icon

Point72 (DIFC)’s Maravai LifeSciences MRVI Stock Holding History

Point72 (DIFC)’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$7.43M Sell
2,588,887
-1,130,615
-30% -$2.89M 0.49% 57
2025
Q2 		$8.96M Buy
3,719,502
+2,163,164
+139% +$4.55M 0.34% 68
2025
Q1 		$3.44M Buy
1,556,338
+561
+0% +$2.22K 0.14% 202
2024
Q4 		$8.48M Sell
1,555,777
-1,104,601
-42% -$7.11M 0.31% 71
2024
Q3 		$22.1M Buy
+2,660,378
New +$23M 0.75% 23

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.05B AUM 22.45% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return

Point72 (DIFC)'s MRVI Position: Q3 2025 in Review

Point72 (DIFC) reduced its Maravai LifeSciences (MRVI) stake by 30% in Q3 2025, selling an estimated $2.89M and leaving 2,588,887 shares worth $7.43M. The position accounts for 0.49% of the portfolio, ranked #57.

Point72 (DIFC) first reported a position in MRVI in Q3 2024 and has held it in 5 quarters since. The position peaked at $22.1M in Q3 2024. 160 funds tracked by Wall St. Rank hold MRVI as of Q3 2025.

  • Point72 (DIFC) held 2,588,887 shares of Maravai LifeSciences worth $7.43M as of Q3 2025.
  • Point72 (DIFC) sold 1,130,615 Maravai LifeSciences shares in Q3 2025, an estimated $2.89M.
  • Maravai LifeSciences made up 0.49% of Point72 (DIFC)'s portfolio in Q3 2025, its #57 holding.
  • Point72 (DIFC) first reported a position in Maravai LifeSciences in Q3 2024 and has held it in 5 quarters since.
  • Point72 (DIFC)'s Maravai LifeSciences position peaked at $22.1M in Q3 2024.
  • 160 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.